Marylyn Rigby

Marylyn Rigby

Chief Communications Officer

Ms. Marylyn Rigby has 2 decades of accomplished pharmaceutical, biotechnology, and medical technology experience. As an accomplished business development, marketing, and investor relations professional, she has navigated a progressive career trajectory into senior management roles and as the Chief Executive Officer of Bioceptive. With an unstoppable drive and passion, Ms. Rigby has successfully led strategic initiatives that have resulted in private placements, an IPO, and secondary follow-on rounds. Recently, as Senior Vice President, she was the creative force behind the brand marketing and identity for SteadyMed Therapeutics and Revolo Biotherapeutics, where her accomplishments were industry recognized.

Scroll to Top